Abilify (aripiprazole) will be the first atypical antipsychotic approved for adolescents

January 2012

Abilify (aripiprazole) will be the first atypical antipsychotic approved for adolescents in Canada.

It's approved for schizophrenia in patients 15 to 17 years old.

But antipsychotics are often used off-label in even younger kids for bipolar disorder, depression, and other psychiatric conditions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Opioids OxyContin will be replaced with OxyNeo to help reduce abuse
Anticoagulants more emphasis on preventing bleeding due to anticoagulants in elderly patients
Women's Health possible higher risk of blood clots with drospirenone OCs or the Evra contraceptive patch
Women's Health Prevegyne (PRE-ve-geen), a vitamin C tablet used VAGINALLY for bacterial vaginosis
Psychiatry Abilify (aripiprazole) will be the first atypical antipsychotic approved for adolescents
Interactions whether citalopram (Celexa, etc) can be used with oral contraceptives or PPIs
Interactions Dexilant (dexlansoprazole) is good for patients on Plavix (clopidogrel) who need a PPI
Hypertension the best time of day to take blood pressure meds
Dyslipidemia whether more KIDS should be screened and treated for high cholesterol
Osteoarthritis Patients often ask what works best for osteoarthritis pain
Cardiology You'll see ondansetron (Zofran, etc) join the list of drugs with stronger warnings about QT prolongation
Diabetes new screening device for diabetes called Scout DS